Takhzyro 47783-0645-01
Generic: Lanadelumab-Flyo
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 3, 2023
- Listing Expires
- December 31, 2026
- Application
- BLA761090
Need to source Takhzyro? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lanadelumab | 150 mg/mL |
Drug Class
Plasma Kallikrein Inhibitor [EPC]Kallikrein Inhibitors [MoA]Plasma Kallikrein Inhibitor [EPC]
Selected Package
47783-0645-01Selected1 SYRINGE, GLASS in 1 CARTON (47783-645-01) / 1 mL in 1 SYRINGE, GLASS